Back to Search
Start Over
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
- Source :
- Diabetes & Metabolism Journal, Vol 48, Iss 4, Pp 730-739 (2024)
- Publication Year :
- 2024
- Publisher :
- Korean Diabetes Association, 2024.
-
Abstract
- Background It is well known that a large number of patients with diabetes also have dyslipidemia, which significantly increases the risk of cardiovascular disease (CVD). This study aimed to evaluate the efficacy and safety of combination drugs consisting of metformin and atorvastatin, widely used as therapeutic agents for diabetes and dyslipidemia. Methods This randomized, double-blind, placebo-controlled, parallel-group and phase III multicenter study included adults with glycosylated hemoglobin (HbA1c) levels >7.0% and 100 and
Details
- Language :
- English
- ISSN :
- 22336079 and 22336087
- Volume :
- 48
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Diabetes & Metabolism Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.372f54b5d78449f7a788cf4561fab040
- Document Type :
- article
- Full Text :
- https://doi.org/10.4093/dmj.2023.0077